Statins' CV benefit outweighs diabetes risk

The Heart Foundation said the analysis – which comes just months after the FDA changed the statin labelling in the US to warn of a small increased risk – “found the diabetes link had been overstated”.

At the time of the FDA’s move in March, lay media reports suggested “thousands of Australians” may be taken off lipid medication due to the risk of diabetes and dementia.

Now, new information on the issue is available from the JUPITER trial, funded by AstraZeneca, which involved more than 17,000 people without cardiovascular disease or diabetes who